Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma.
Wong JP, Stuhlmiller TJ, Giffin LC, Lin C, Bigi R, Zhao J, Zhang W, Bravo Cruz AG, Park SI, Earp HS, et al. Proc Natl Acad Sci U S A. 2019 Aug 13; 116(33):16541-16550. Epub 2019 Jul 25.